Braze stock price target lowered to $43 by UBS on growth outlook

Braze Inc. (BRZE) reported robust Q2 FY2026 results, with EPS of $0.15 significantly surpassing estimates and revenue growing 24% year-over-year to $180.1 million, driven by broad-based demand. Mizuho responded by raising its price target to $45.00 with an Outperform rating. UBS, while adjusting its price target to $43.00, maintained a Buy rating, citing Braze's strong balance sheet, consistent 20%+ organic revenue growth, 68.79% gross margin, and improved operating income outlook, noting its rarity among application companies. Despite these strong fundamentals and analyst optimism, the stock experienced a slight aftermarket dip.

Analysis

Braze Inc. (BRZE) delivered a significant beat in its Q2 FY2026 results, with earnings per share of $0.15 massively outperforming the $0.03 consensus, a 400% surprise. This was underpinned by a 24% year-over-year revenue increase to $180.1 million, which also surpassed projections, driven by robust demand and moderating customer down-sells. In response, Mizuho raised its price target to $45. While UBS trimmed its target to $43, it maintained a 'Buy' rating, signaling strong underlying conviction. UBS's thesis is built on evidence of sustainable organic revenue growth in the 20% range, a strong balance sheet, and a robust 68.79% gross margin. The firm also highlighted positive forward-looking indicators, including stabilizing net revenue retention and strong growth in current remaining performance obligations (cRPO). Critically, Braze demonstrated improving operational leverage, raising its operating income guidance by $17.5 million, which outpaced its $14.5 million revenue guidance increase and implies an operating margin of 3.5%. UBS contends the stock merits a re-rating, noting its valuation of approximately 3x estimated CY2026 EV/Sales is attractive for a rare software company exhibiting a stable to improving high-growth profile, a positive outlook that contrasts with a slight dip in the stock's aftermarket trading.

Key Decisions for Investors

• Given the significant earnings beat, improving operational leverage, and strong analyst conviction, investors may view the slight aftermarket stock dip as a potential entry point into a high-growth name.
• It is crucial to monitor the key performance indicators cited in the bull case, particularly net revenue retention and cRPO growth, to ensure the 20%+ revenue growth thesis remains intact.
• Consider the valuation argument; if Braze sustains its growth and margin expansion, its current multiple of approximately 3x estimated CY2026 EV/Sales could offer significant upside potential through a market re-rating relative to software peers.
• The divergence between UBS's price target cut and its maintained 'Buy' rating suggests a focus on the long-term fundamental story over short-term valuation adjustments, a perspective investors should also consider.